Catheter Precision Announces September 10th, 2025 Record Date for October 10th, 2025 Special Meeting of Stockholders

Catheter Precision has announced September 10th, 2025 as the record date for its October 10th special meeting of stockholders. The company is seeking stockholder approval to amend its Certificate of Incorporation to increase authorized common stock shares and appoint WithumSmith+Brown, PC as its independent auditor for fiscal year 2026. The preliminary proxy statement is expected to be filed with the SEC on September 4th, 2025.

Title: Catheter Precision Sets Record Date for Upcoming Special Meeting of Stockholders

Catheter Precision (NYSE: VTAK), a leading medical device company focused on cardiac electrophysiology, has announced September 10th, 2025, as the record date for its upcoming Special Meeting of Stockholders scheduled for October 10th, 2025 [1]. During the meeting, stockholders will vote on two key proposals: increasing the company's authorized shares of common stock and appointing WithumSmith+Brown, PC as the independent auditor for fiscal year 2026. The preliminary proxy statement detailing these matters is expected to be filed with the SEC on September 4th, 2025.

The record date is crucial as it determines which shareholders are eligible to vote at the meeting. On September 10th, 2025, the company will check its records to identify shareholders of record as of that date. The preliminary proxy statement, which will be available for review by shareholders, is anticipated to provide detailed information about the proposed changes and the rationale behind them.

Catheter Precision, based in Fort Mill, South Carolina, is known for its innovative products that improve the treatment of cardiac arrhythmias. The company's focus on developing advanced technology for electrophysiology procedures has made it a significant player in the medical device industry.

The proposed increase in authorized shares of common stock aims to provide the company with additional financial flexibility to support its growth and innovation. Appointing WithumSmith+Brown, PC as the independent auditor for fiscal year 2026 is part of the company's ongoing efforts to maintain robust financial governance and transparency.

Shareholders are encouraged to review the preliminary proxy statement, which will be available on the SEC's website and the company's website. The proxy statement will include detailed information about the proposed changes, the rationale behind them, and the potential impact on the company's financial health.

Catheter Precision's forward-looking statements, as outlined in the preliminary proxy statement, should be approached with caution. The company acknowledges that actual outcomes may differ from the expectations and projections outlined in the statement. Investors are advised to review the full proxy statement and the company's Form 10-K filing with the SEC for a comprehensive understanding of the risks and uncertainties involved.

References:
[1] https://www.stocktitan.net/news/VTAK/catheter-precision-announces-september-10th-2025-record-date-for-zm3hhfb9qx6o.html